"Mesothelioma Information"

Mesothelioma clinical trial is done in various countries due to the higher significance of the problems associated with mesothelioma. Mesothelioma clinical trial is welcome one but should be a streamlined one on scientific basis.

It is to be remembered that in United States of America itself the number of cases of mesothelioma are increasing in every year and this is true with many other countries also.

Clinical trial is being conducted with a person  when the treatment is expected to yield benefits  in such persons and is taken as a promising experiment. The clinical trials are also governed by suitable laws and are well revealed by any of the related attorneys in various states.

There are different phases in the trials. The phase I is mainly related to the safety features of the patient who is affected with mesothelioma and is undergoing the new clinical trial.

The research therapy is tested in animals. However, some side effects in the patient might not be predictable.

The next phase or phase II, the effectiveness of the treatment is being evaluated because the safety measures were evaluated in previous trial itself. However, if any side effect is still noticed, just document this, in a more careful manner in order to compare the other treatment measures, that may be carried out in future.

In the third trial, a standard group or the control group receives therapy with a known medicament tested earlier and is a larger group. Another group may receive another chemotherapy agent and the results are compared and the side effects during the therapy are also noted down.

Clinical trials are generally undertaken with the concurrence of the concerned person who has been affected by mesothelioma. However, every research institution is having a protocol related to the clinical trials.

The persons who fits with various requisites like age, stage, type etc. only are subjected to such trials and the  drug may or may not yield the expected effects, some times in mesothelioma clinical trials.

It is always better to check with the financial institutions pertaining to the mesothelioma and law firms that are familiar with such trials or the specific Mesothelioma attorney who presents various facts on mesothelioma including features on clinical trials.

Mesothelioma diagnosis plays an important role in treatment of the same. Doctors usually collect blood to identify the tumor cells. The other methods of diagnosis of mesothelioma are discussed below-

The fluid present in the pleura is taken out by chest drain or pleural tap. In case of the fluid accumulation in the peritoneum, the fluid is collected by paracentesis. Pericardiocentesis is performed to get the fluid from the pericardium. Absence of abnormal cells in the fluid collected, not necessarily rules out existence of mesothelioma.

By any chance the cytology is positive, [I mean if there is any abnormal cells noticed] the doctor will conduct the biopsy test to confirm the cancerous growth. Biopsy is nothing but pathological examination of the cells collected from the tumor or excess growth of the affected organ or tissue.

There are different ways of performing the biopsy. One technique is called thoracoscopy. Thoracoscopy is important for the pleural mesothelioma diagnosis.

In this procedure, small cut is made in the wall of the chest. A light, thin tube called thoracoscope is inserted in to the small cut made in the chest wall. The tissue sample is collected by the thoracoscope. In this technique the doctor can take the tissue sample with minimum damage to the body and also can have look inside the chest.

In case of mesothelioma of peritoneum, the doctor performs laparoscopy. Laparoscopy helps mesothelioma diagnosis in a big way. As per this technique a small incision is made in the wall of the abdomen.

A small instrument called laparoscope is inserted to get the tissue samples out of the body. The tissue sample thus collected will be subjected to pathological studies to find out the abnormal cells whose presence will confirm mesothelioma diagnosis. In case the laparoscopy is not sufficient to take the tissue samples, a much more extensive surgery may be performed by the doctor.

Rosetta Genomics, Ltd holds it hand with NYU Medical center to develop early diagnostic products for Asbestos Lung cancer (Mesothelioma) and other lung ailments.

According to this program, nearly 45 million Americans who are at the brink of Mesothelioma due to exposure to asbestos fibers, as well as those who are smokers.

This test mainly aims at extracting microRNAs from a simple blood draw from the suspected persons. This is the main protocol for the Rosetta Genomics’ Ltd.

Dr. Harvey Pass, Professor and Chief, Division of Thoracic Surgery and Thoracic Oncology at NYU Medical Center opined that this simple test of  detecting lung cancer will really have far reaching implication on the fight against cancer.

The researchers confirmed that microRNAs are having great potential to act as a perfect biomarkers for various cancers including asbestos lung cancer.

We can hope for the best as the two giants- NYU medical center and Rosetta Genomics provide a real boon in early diagnosis of mesothelioma by means of microRNA diagnosis.